Bioequivalence Trial of a New Opioid Combination Compared to Reference
NCT00460785
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
32
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
Opioid
Sponsor
Grünenthal GmbH